We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

D05:SGXDBS Group Holdings Ltd Analysis

Data as of 2026-05-29 - not real-time

SGD 62.84

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

DBS shares are trading at their 52‑week high of S$62.84, sitting just above the 20‑day (S$60.35) and 50‑day (S$58.47) moving averages, with a bullish MACD crossover and a strong uptrend signal. However, the RSI of 78 signals an overbought condition and the recent decline in volume suggests weakening momentum as the price approaches the identified resistance of S$62.84. The bank reported record total income in Q1 2026, driven by wealth‑management growth that helped offset interest‑rate headwinds, reinforcing its earnings resilience. With a dividend yield of 5.23% and a payout ratio near 80%, the dividend appears sustainable given consistent earnings per share.
From a valuation perspective, DBS’s forward P/E of ~15 aligns closely with the industry average, indicating a fairly valued position despite the recent price rally. Low beta (0.35) and moderate 30‑day volatility (≈14%) point to a stable risk profile, while the bank’s strong capital base and diversified regional footprint mitigate sector and geographic risks. The technical overbought signal suggests a short‑term pause, but the underlying fundamentals and attractive dividend support a buy stance for medium‑ and long‑term horizons.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • RSI in overbought territory
  • Price at technical resistance
  • Decreasing trading volume

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Sustainable high dividend yield
  • Record Q1 income and wealth‑management tailwinds
  • Bullish trend with strong moving‑average support

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Low beta and moderate volatility
  • Diversified regional presence reducing concentration risk
  • Consistent profitability and solid capital position

Key Metrics & Analysis

Financial Health

Revenue Growth3.20%
Profit Margin49.20%
P/E Ratio16.4
P/B Ratio2.6
Industry P/E16.5

Technical Analysis

TrendBullish
RSI78.4
SupportSGD 57.80
ResistanceSGD 62.84
MA 20SGD 60.35
MA 50SGD 58.47
MA 200SGD 55.50
MACDBullish
VolumeDecreasing
Fear & Greed Index93.14

Valuation

Target PriceSGD 60.42
Upside/Downside-3.85%
GradeFair
TypeBlend
Dividend Yield5.23%

Risk Assessment

Beta0.35
Volatility13.88%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.